Ovarian germ cell tumor epidemiology and demographics: Difference between revisions

	Ovarian germ cell tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Ovarian germ cell tumor from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Surgery
Chemotherapy
Radiotherapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ovarian germ cell tumor epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ovarian germ cell tumor epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ovarian germ cell tumor epidemiology and demographics
CDC on Ovarian germ cell tumor epidemiology and demographics
Ovarian germ cell tumor epidemiology and demographics in the news
Blogs on Ovarian germ cell tumor epidemiology and demographics
Directions to Hospitals Treating Ovarian germ cell tumor
Risk calculators and risk factors for Ovarian germ cell tumor epidemiology and demographics

Revision as of 14:53, 17 November 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

OGCTs are rare tumors, accounting for 2% to 3% of all ovarian cancers. The median age for diagnosis is 16 to 20 (range 6 to 40 years)

OGCTs are rare tumors, accounting for 2% to 3% of all ovarian cancers. The median age for diagnosis is 16 to 20 (range 6 to 40 years)

@@ Line 3: / Line 3: @@
 {{CMG}}{{AE}} {{MD}}
-OGCTs are rare tumors, accounting for 2% to 3% of all ovarian cancers and develop usually in young women. The median age for diagnosis is 16 to 20 (range 6 to 40 years).1 Ethnic and racial differences have been noted in an analysis extracted from the Surveillance, Epidemiology, and End Results (SEER) database, with increased incidence of OGCTs among pediatric black females compared with black males and among Hispanic girls age 10-19 compared with non-Hispanic girls. Interestingly, a case-cohort study from the Children's Oncology Group that included 274 cases (195 OGCT and 79 testicular cancers) showed an inverse association between family history of ovarian or uterine cancers and GCT in girls (OR = 0.46, 95% CI 0.22-0.96).
+==Overview==
+OGCTs are rare tumors, accounting for 2% to 3% of all ovarian cancers. The median age for diagnosis is 16 to 20 (range 6 to 40 years)
+==Epidemiology and Demographics==
+OGCTs are rare tumors, accounting for 2% to 3% of all ovarian cancers. The median age for diagnosis is 16 to 20 (range 6 to 40 years)
-Dysgerminoma is the female equivalent of seminoma and represents the most common OGCT.5 Five to 10% are associated with gonadoblastomas and develop in patients who are sexually mal-developed. Dysgerminoma is the most common OGCT in young adult women whereas yolk sac tumor is the most common histology in younger pediatric and adolescent women.
 ==References==